Correlation Between Axsome Therapeutics and BioXcel Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and BioXcel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and BioXcel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Therapeutics and BioXcel Therapeutics, you can compare the effects of market volatilities on Axsome Therapeutics and BioXcel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of BioXcel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and BioXcel Therapeutics.

Diversification Opportunities for Axsome Therapeutics and BioXcel Therapeutics

-0.28
  Correlation Coefficient

Very good diversification

The 3 months correlation between Axsome and BioXcel is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and BioXcel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioXcel Therapeutics and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with BioXcel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioXcel Therapeutics has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and BioXcel Therapeutics go up and down completely randomly.

Pair Corralation between Axsome Therapeutics and BioXcel Therapeutics

Given the investment horizon of 90 days Axsome Therapeutics is expected to generate 0.33 times more return on investment than BioXcel Therapeutics. However, Axsome Therapeutics is 3.0 times less risky than BioXcel Therapeutics. It trades about -0.2 of its potential returns per unit of risk. BioXcel Therapeutics is currently generating about -0.13 per unit of risk. If you would invest  9,703  in Axsome Therapeutics on September 27, 2024 and sell it today you would lose (900.00) from holding Axsome Therapeutics or give up 9.28% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Axsome Therapeutics  vs.  BioXcel Therapeutics

 Performance 
       Timeline  
Axsome Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Axsome Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Axsome Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
BioXcel Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioXcel Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Axsome Therapeutics and BioXcel Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Axsome Therapeutics and BioXcel Therapeutics

The main advantage of trading using opposite Axsome Therapeutics and BioXcel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, BioXcel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioXcel Therapeutics will offset losses from the drop in BioXcel Therapeutics' long position.
The idea behind Axsome Therapeutics and BioXcel Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation